ABRA antibody (AA 13-381) (FITC)
Quick Overview for ABRA antibody (AA 13-381) (FITC) (ABIN7965643)
Target
See all ABRA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 13-381
-
Purpose
- Anti-ABRA Antibody FITC Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human ABRA recombinant protein (Position: A13-K381).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Alternative Name
- ABRA
-
Background
-
Background: Predicted to enable actin binding activity. Predicted to be involved in positive regulation of DNA-binding transcription factor activity, positive regulation of Rho protein signal transduction, and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within positive regulation of transcription, DNA-templated and protein import into nucleus. Located in plasma membrane.
Gene Full Name: actin binding Rho activating protein
-
Gene ID
- 137735
-
UniProt
- Q8N0Z2
-
Pathways
- Protein targeting to Nucleus
Target
-